Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Argus Research Upgrades Biogen to Buy

Argus Research Upgrades Biogen to Buy

Argus Research analyst Jasper Hellweg upgrades Biogen (NASDAQ:BIIB) from Hold to Buy.

October 7, 2022

1 minute read

Argus Research analyst Jasper Hellweg upgrades Biogen (NASDAQ:BIIB) from Hold to Buy.

Amazon’s Q2 Earnings Impress; Focus On AI And Margin Improvement Praised By Analysts

August 4, 11:40 AM

Shares of Amazon.com, Inc. (NASDAQ: AMZN) climbed in early trading on Friday, after the company reported blowout profits for the second quarter.

July 19, 1:30 PM

In the current market session, Intercontinental Exchange Inc. (NYSE:ICE) stock price is at $115.85, after a 0.19% drop.…

October 31, 9:05 AM

Morgan Stanley analyst Ricky Goldwasser maintains Humana (NYSE:HUM) with a Overweight and raises the price target from $549 to $620.

May 28, 11:00 AM

27 analysts have shared their evaluations of Uber Technologies (NYSE:UBER) during the recent three months, expressing a mix…